Ryan White Care Hepatitis C & B Language
NATAP Webinars:
Friday 12:30pm EST - March 27th, 2026
HIV Treatment Strategies & Prevention; CROI 2026
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
Comprehensive study of cerebrospinal fluid β2-microglobulin, a marker of central nervous system immune activation in individuals with HIV
- (03/14/26)
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial
- (03/14/26)
Social cognition in people with HIV: a neglected cognitive domain?
- (03/14/26)
Dementia incidence and prevalence in older adults with HIV: a 23-year retrospective cohort study
- (03/14/26)
Fixed-dose daily doravirine (100 mg) with islatravir (0⋅25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
- (03/14/26)
Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial
- (03/14/26)
CROI:
The Impact of SEARCH Community Precision Health on HIV Incidence in Rural Kenya and Uganda
- (03/12/26)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
CROI:
Efficacy and Safety of Long-Term Bulevirtide in Chronic Hepatitis Delta: Final Results From the Phase 3 MYR301 Study, Including 2 Participants With HIV/HBV/HDV Coinfection
- (02/26/26)
More Hep D Articles...
Aging & Perinatally Acquired HIV
CROI:
Longitudinal Associations of Semaglutide with Liver Fibrosis Score in People with HIV
- (03/11/26)
CROI:
Cell type-specific mitochondrial function and T cell dynamics in people with and without HIV
- (03/10/26)
CROI:
Mitochondrial DNA Copy Number and Cardiovascular-Kidney-Metabolic Syndrome in People with HIV
- (03/10/26)
CROI:
Change and Interaction Between Mitochondrial DNA Copy Number and Epigenetic After HIV Seroconversion
- (03/10/26)
CROI:
GLP-1 Receptor Agonists: Are They a Cure for Everything?
- (03/10/26)
CROI:
The GrimAge clock corresponds to accelerated brain aging and executive dysfunction in people with HIV
- (03/10/26)
CROI:
Projecting State-Level Aging Patterns Among People with HIV in the United States
- (03/09/26)
More Aging & HIV Articles...
PrEP
CROI:
Beating the Clock: Timing 10E8.4/iMab Administration to Block SHIV Infection
- (03/10/26)
CROI:
National LAI-PrEP Use and Retention in Care in the United States, 2022-2024
- (03/09/26)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies
- (03/13/26)
CROI:
Simple Adiposity Measures Identify MASLD in People with HIV: Results from a US Multicenter Cohort
- (03/07/26)
CROI:
Effect of DTG/3TC vs. BIC/FTC/TAF on Steatotic Liver Disease: 96-week Analysis of PASO-DOBLE Trial
- (03/07/26)
CROI:
Elevated Triglyceride and Ceramide Metabolites in MASLD among PWH
- (03/07/26)
CROI:
Prevalence and Risk Factors for Steatotic Liver Disease in PWH with Resolved HCV
- (03/07/26)
CROI:
Point-of-Care HCV RNA Compared to Laboratory-Based HCV RNA in a Tribal Health Setting
- (03/04/26)
CROI:
HIV Status Drives Distinct Immune Pathways of Persistent Portal Hypertension After HCV Cure
- (03/04/26)
CROI:
Baseline Plasma and T-cell Immune Profiles Linked to Liver Stiffness Regression After HCV Cure
- (03/04/26)
CROI:
Glecaprevir/Pibrentasvir Combination Within Individual Particles Drives Optimal LAI Performance
- (03/04/26)
CROI:
Progressing towards global hepatitis C elimination: a systematic review and meta-analysis of care cascades in key populations
- (02/26/26)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
CROI:
VRON-0200 Induced Broad and Sustained Anti-HBV Immunity in Chronically HBV-Infected Patients
- (02/28/26)
AASLD:
Safety, Pharmacokinetics, and Antiviral Activity of the Next-Generation Hepatitis B Capsid Assembly Modulator ABI-4334 in Patients With HBeAg-Negative Chronic Hepatitis B Infection Not Suppressed on Nucleoside Analogues: Results From a Randomized, Blinded, Phase 1b Study
- (12/29/25)
AASLD:
Impact of Baseline HBeAg Status on HBV Outcomes in the ALLIANCE Study
- (11/24/25)
AASLD:
Characterization of HIV/HBV Co-infected Participants Achieving High Rates of Hepatitis B Surface Antigen (HBsAg) Loss in the ALLIANCE Phase 3 Clinical Study
- (11/24/25)
More Hep B Articles...
Fatty Liver, NAFLD, NASH, MASLD, MASH
Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- (02/19/26)
A Phase 2b, Multicenter, Randomized, Placebo- Controlled Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis
- (12/29/25)
Reduction of Liver Fibrosis by Al-Based Digital Pathology Analysis: Results from the Pemvidutide Phase 2b IMPACT Trial
- (12/29/25)
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
- (12/29/25)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
Conference List Here
https://www.croiconference.org/
https://academicmedicaleducation.com/programs/3rd-african-workshop-on-women-and-hiv-2026
https://academicmedicaleducation.com/programs/16th-international-workshop-on-women-and-hiv-2026
https://acthiv.org/
https://ddw.org/?doing_wp_cron=1768748258.8390960693359375000000
https://www.easlcongress.eu/ https://congress-easl.com/
https://asm.org/events/asm-microbe/home
https://academicmedicaleducation.com/programs/24th-european-meeting-on-hiv-and-hepatitis-2026
https://www.iasociety.org/conferences/aids2026
https://academicmedicaleducation.com/programs?page=2
https://academicmedicaleducation.com/programs/27th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-and-other-antiviral-drugs-2026
https://academicmedicaleducation.com/programs/9th-conference-on-liver-disease-in-africa-colda-2026
https://academicmedicaleducation.com/programs/17th-international-workshop-on-aging-and-hiv-2026
https://idweek.org/
https://aasld-igh.org/Home.aspx https://www.aasld.org/the-liver-meeting
https://hivglasgow.org/
